cbdMD, Inc. to Host Conference Call to Discuss March 31, 2021, Second Quarter Results
May 03 2021 - 12:00PM
Business Wire
cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the world’s
leading, and most highly trusted and recognized health &
wellness CBD companies, announced today that it will host a
conference call at 4:15 p.m., Eastern Time, on Wednesday, May 12th,
2021, to discuss the company’s March 31, 2021 second quarter
financial results and business progress.
CONFERENCE CALL DETAILS
Wednesday, May 12th, 2021, 4:15 p.m.
Eastern Time
Domestic:
1-888-506-0062
International:
1-973-528-0011
Replay dial in – Available through Friday,
June 11, 2021
Domestic:
1-877-481-4010
International:
1-919-882-2331
Replay Passcode:
41216
Webcast Link/Webcast Replay link-
available through Thursday, May 12, 2022:
https://www.webcaster4.com/Webcast/Page/2206/41216
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most highly trusted and
most recognized cannabidiol (CBD) brands with a comprehensive line
of U.S. produced, THC-free1 CBD products. Our cbdMD brand currently
includes over 130 SKU’s of high-grade, premium CBD products
including CBD tinctures, CBD gummies, CBD topicals, CBD capsules,
CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes.
Our Paw CBD brand of pet products includes over 45 SKUs of
veterinarian-formulated products including tinctures, chews,
topicals products in varying strengths, and our CBD Botanicals
brand of beauty and skincare products features 15 SKUs, including
facial oil and serum, toners, moisturizers, clear skin, facial
masks, exfoliants and body care. Please visit www.cbdMD.com, follow
cbdMD on Instagram and Facebook, or visit one of the 6,000 retail
outlets that carry cbdMD products. To learn more about cbdMD and
their comprehensive line of U.S. grown, THC-free1 CBD oil products,
please visit www.cbdmd.com.
Forward-Looking Statements
This press release contains certain forward-looking statements
that are based upon current expectations and involve certain risks
and uncertainties within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Such forward-looking statements can
be identified by the use of words such as ''should,'' ''may,''
''intends,'' ''anticipates,'' ''believes,'' ''estimates,''
''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and
''proposes.'' These forward-looking statements are not guarantees
of future performance and are subject to risks, uncertainties, and
other factors, some of which are beyond our control and difficult
to predict. You are urged to carefully review and consider any
cautionary statements and other disclosures, including the
statements made under the heading "Risk Factors" in cbdMD, Inc.'s
Annual Report on Form 10-K for the fiscal year ended September 30,
2020 as filed with the Securities and Exchange Commission (the
"SEC") on December 22, 2020 and our other filings with the SEC. All
forward-looking statements involve significant risks and
uncertainties that could cause actual results to differ materially
from those in the forward-looking statements, many of which are
generally outside the control of cbdMD, Inc. and are difficult to
predict. cbdMD, Inc. does not undertake any duty to update any
forward-looking statements except as may be required by law. The
information which appears on our websites and our social media
platforms, including, but not limited to, Instagram and Facebook,
is not part of this press release.
1 THC-free is defined as below the level of detection using
validated scientific analytical tools.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210503005471/en/
PR: 5W Public Relations cbdMD@5wpr.com (212) 999-5585 Investors:
cbdMD, Inc., John Weston, Director of Investor Relations
John.Weston@cbdMD.com (704) 249-9515
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Mar 2024 to Apr 2024
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Apr 2023 to Apr 2024